These same pathways connect to your reproductive hormone system, creating potential cross-talk between weight-loss signaling and estrogen/progesterone balance
Eli Lilly sponsored SURMOUNT-5, (NCT05822830), a Phase IIIb, open label, multi-centre, randomised clinical trial to compare the efficacy and safety of tirzepatide (Zepbound) versus semaglutide (Wegovy) in overweight or obese adults and at least one additional named weight-related comorbidity that was not T2D 24
A meta-analysis showed that TNF- levels were significantly associated with declined muscle strength (grip strength, gait speed) and reduced muscle mass in older patients with sarcopenia
Hydrate: Drink plenty of water throughout the day to support your body's natural detox processes
While the upfront price of these drugs is high, they may save money in the long run by reducing the prevalence of obesity-related diseases, such as diabetes and heart disease, which are much more costly to treat
I love this part of my job: I get to follow the science, stay curious, and make sure youre empowered with the facts